1-4 of 4
Paul W Eldridge
Close
Sort by
Journal Articles

Stem Cell Mobilization Characteristics for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) Treated with Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab (KRd-Dara)

Manisha Bhutani, Myra Robinson, Shebli Atrash, Nicole Watts, Barry Paul, Saurabh Chhabra, Neha Korde, Xhevahire Begic, David M Foureau, David J. Chung, Mauricio Pineda-Roman, Brinda Koya, Cindy Varga, Jing Ai, Natonya Daniels, Sarah Norek, Sara A Sutton, Michelle B Anderson, Ashley N Jewell, Paul W Eldridge, Donna Acampora, James T Symanowski, Luciano J. Costa, Saad Usmani, Peter M. Voorhees
Journal: Blood
Blood (2022) 140 (Supplement 1): 4393–4395.
https://doi.org/10.1182/blood-2022-160071
Published: 2022
Journal Articles

Depletion of CD45RA+ Cells from Mobilized Peripheral Blood Stem Cell (PBSC) Collections As an Integral Part of Hematopoietic Stem Cell Transplantation (HSCT) and Cellular Therapy (CT)

Ping Law, PhD, Paul W. Eldridge, PhD, James Houston, Brandon M. Triplett, MD, David R Shook, MD, Wing Leung, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1130.
https://doi.org/10.1182/blood.V124.21.1130.1130
Published: 2014
Journal Articles

Transduction of Human CD34+ Derived NSG Repopulating Cells with An Insulated SIN Lentiviral Vector for SCID-X1 From a Stable Producer Cell Line At Clinical Scale

Michael R. Greene, MD, Timothy Lockey, PhD, John T. Gray, PhD, Paul W. Eldridge, PhD, Yoon-Sang Kim, MD, PhD, Perdeep K. Mehta, PhD, Brian P. Sorrentino, MD
Journal: Blood
Blood (2011) 118 (21): 670.
https://doi.org/10.1182/blood.V118.21.670.670
Published: 2011
Journal Articles

Expanded Natural Killer Cells for Cellular Therapy of Acute Myeloid Leukemia.

Hiroyuki Fujisaki, MD, PhD, Harumi Kakuda, MD, PhD, Timothy Lockey, PhD, Paul W. Eldridge, PhD, Wing Leung, MD, PhD, Dario Campana, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2743.
https://doi.org/10.1182/blood.V110.11.2743.2743
Published: 2007